XML 111 R68.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 12 Months Ended
Jun. 18, 2024
shares
May 22, 2022
shares
Jan. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
period
$ / shares
vote
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Oct. 31, 2010
$ / shares
shares
Stockholders' Equity [Line Items]              
Common stock, shares authorized (in shares)       1,000,000,000 1,000,000,000   1,000,000,000
Common stock, par value (in dollars per share) | $ / shares     $ 0.001 $ 0.001 $ 0.001   $ 0.001
Preferred stock, shares authorized (in shares)       50,000,000 50,000,000   50,000,000
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.001 $ 0.001   $ 0.001
Preferred stock, shares issued (in share)       0 0    
Preferred stock, shares outstanding (in shares)       0 0    
Common stock, dividends declared (in usd per share) | $ / shares       $ 0      
Voting right of common stock share holders       one      
Voting right of common stock share holders, number of votes | vote       1      
Public offering (in shares)     17,500,000        
Common stock offering price (in usd per share) | $ / shares     $ 10.00        
Public offering, option to purchase additional shares, period     30 days        
Public offering, option to purchase additional shares (in shares)     2,600,000        
Commissions, percentage of gross proceeds     5.75%        
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $     $ 189.7        
Payments of offering expense | $     $ 0.5        
Weighted average remaining contractual term       5 years 1 month 6 days      
Vested and expected to vest, aggregate intrinsic value | $       $ 0.1      
Vested and expected to vest, weighted average exercise price (in usd per share) | $ / shares       $ 11.13      
Vested and expected to vest, weighted average remaining contractual life       5 years 4 months 24 days      
Intrinsic value | $       $ 0.8 $ 8.8 $ 5.0  
Weighted average grant date fair value (in usd per share) | $ / shares       $ 1.40 $ 7.32 $ 5.93  
Common stock, shares issued (in shares)       294,418,000 267,744,000    
Stock-based compensation cost capitalized in inventory | $       $ 0.6 $ 0.6    
Dividend yield       0.00% 0.00% 0.00%  
2020 Plan, Inducement Plan, And The Omniome Plan              
Stockholders' Equity [Line Items]              
Common stock remain available for issuance (in shares)       28,400,000      
Shelf Offering              
Stockholders' Equity [Line Items]              
Shares issued (in shares)     20,100,000        
Options To Purchase Common Stock              
Stockholders' Equity [Line Items]              
Stock price (in usd per share) | $ / shares       $ 1.83      
Weighted average grant date fair value (in usd per share) | $ / shares       $ 1.40 $ 7.32 $ 5.93  
Dividend yield       0.00% 0.00% 0.00%  
Proceeds from stock options exercised | $       $ 1.6 $ 6.5 $ 3.4  
Total unrecognized compensation expense | $       80.1      
Time-Based and Performance-Based Options              
Stockholders' Equity [Line Items]              
Intrinsic value | $       $ 0.1      
Period for recognition       5 years 4 months 24 days      
Options, exercisable, number (in shares)       9,429,082      
Options expired, weighted average exercise price (in usd per share) | $ / shares       $ 11.26      
Vested and expected to vest, outstanding (in shares)       10,957,644      
Restricted Stock Units (RSUs)              
Stockholders' Equity [Line Items]              
Ratio of number of shares into which the share instrument may be converted       1      
Award vesting period       4 years      
Total fair value of shares vested related to RSUs | $       $ 47.2 $ 39.3 $ 39.2  
Weighted average grant date fair value, granted (in usd per share) | $ / shares       $ 5.02 $ 9.65 $ 10.15  
Time Based Restricted Stock Units PSU              
Stockholders' Equity [Line Items]              
Amount eligible to vest upon achievement of goal       2      
2020 Equity Incentive Plan              
Stockholders' Equity [Line Items]              
Additional common stock reserved for issuance (in shares) 20,000,000 18,000,000          
ESPP              
Stockholders' Equity [Line Items]              
Common stock remain available for issuance (in shares)       14,300,000      
Shares reserved for future issuance (in shares)       33,500,000      
Number of purchase periods | period       4      
Purchase period of ESPP       6 months      
Percentage of fair market value at which stock can be purchased       85.00%      
Percentage of outstanding common stock used to determine annual plan increase       2.00%      
Common stock, shares issued (in shares)       4,000,000      
Common stock purchased under plan (in shares)       1,906,529 1,735,058 1,878,168  
Proceeds from stock options exercised | $       $ 6.1 $ 8.8 $ 7.8  
Common Stock | Options To Purchase Common Stock              
Stockholders' Equity [Line Items]              
Period for recognition       2 years 2 months 12 days